Nagy Sara, Pagnamenta Alistair T, Cali Elisa, Braakman Hilde M H, Wijntjes Juerd, Kusters Benno, Gotkine Marc, Elpeleg Orly, Meiner Vardiella, Lenberg Jerica, Wigby Kristen, Friedman Jennifer, Perry Luke D, Rossor Alexander M, Uhrova Meszarosova Anna, Thomasova Dana, Jacob Saiju, O'Driscoll Mary, De Simone Lenika, Grange Dorothy K, Sommerville Richard, Firoozfar Zahra, Alavi Shahryar, Mazaheri Mahta, Parmar Jevin M, Lamont Phillipa J, Pini Veronica, Sarkozy Anna, Muntoni Francesco, Ravenscroft Gianina, Jones Eppie, O'Rourke Declan, Nel Melissa, Heckmann Jeannine M, Kvalsund Michelle, Kapapa Musambo M, Wa Somwe Somwe, Bearden David R, Çakar Arman, Childs Anne-Marie, Horvath Rita, Reilly Mary M, Houlden Henry, Maroofian Reza
Centre for Neuromuscular Diseases, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Department of Neurology, University Hospital Basel, University of Basel, Basel 4031, Switzerland.
Brain Commun. 2024 Oct 28;6(6):fcae377. doi: 10.1093/braincomms/fcae377. eCollection 2024.
A newly identified subtype of hereditary axonal motor neuropathy, characterized by early proximal limb involvement, has been discovered in a cohort of 34 individuals with biallelic variants in von Willebrand factor A domain-containing 1 (). This study further delineates the disease characteristics in a cohort of 20 individuals diagnosed through genome or exome sequencing, incorporating neurophysiological, laboratory and imaging data, along with data from previously reported cases across three different studies. Newly reported clinical features include hypermobility/hyperlaxity, axial weakness, dysmorphic signs, asymmetric presentation, dystonic features and, notably, upper motor neuron signs. Foot drop, foot deformities and distal leg weakness followed by early proximal leg weakness are confirmed to be initial manifestations. Additionally, this study identified 11 novel variants, reaffirming the 10 bp insertion-induced p.Gly25ArgfsTer74 as the most prevalent disease-causing allele, with a carrier frequency of ∼1 in 441 in the UK and Western European population. Importantly, VWA1-related pathology may mimic various neuromuscular conditions, advocating for its inclusion in diverse gene panels spanning hereditary neuropathies to muscular dystrophies. The study highlights the potential of lower quality control filters in exome analysis to enhance diagnostic yield of VWA1 disease that may account for up to 1% of unexplained hereditary neuropathies.
在一组34名患有含血管性血友病因子A结构域1(VWA1)双等位基因变异的个体中,发现了一种新鉴定出的遗传性轴索性运动神经病亚型,其特征为早期近端肢体受累。本研究通过对20名经基因组或外显子组测序确诊的个体组成的队列进行进一步描述,纳入了神经生理学、实验室和影像学数据,以及来自三项不同研究中先前报道病例的数据。新报道的临床特征包括关节活动过度/关节松弛、轴性肌无力、畸形体征、不对称表现、肌张力障碍特征,尤其是上运动神经元体征。足下垂、足部畸形和小腿远端无力随后出现早期小腿近端无力被确认为初始表现。此外,本研究鉴定出11种新的变异,再次确认10bp插入导致的p.Gly25ArgfsTer74是最常见的致病等位基因,在英国和西欧人群中的携带频率约为1/441。重要的是,VWA1相关病理学可能模仿各种神经肌肉疾病,主张将其纳入从遗传性神经病到肌肉营养不良的各种基因检测板中。该研究强调了外显子组分析中较低质量控制筛选的潜力,以提高VWA1疾病的诊断率,该疾病可能占不明原因遗传性神经病的1%。